Vanguard Global Advisers »

Vir Biotechnology shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $451k 50k 8.96

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Vir Biotechnology

BlackRock
Arch Venture Corp
Vanguard Group
Sb Investment Advisers
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
FMR
Morgan Stanley
ADAR1 Capital Management
Geode Capital Management
Dimensional Fund Advisors
Citadel Advisors
Soleus Capital Management

View all funds holding Vir Biotechnology